Literature DB >> 25759495

Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.

K Field1, D J Murphy2.   

Abstract

STUDY QUESTION: Is a history of three or more miscarriages associated with adverse perinatal outcomes in a subsequent pregnancy? SUMMARY ANSWER: Recurrent miscarriage is associated with an increased risk of adverse perinatal outcomes, including preterm birth, very preterm birth and perinatal death, in a subsequent pregnancy. WHAT IS KNOWN ALREADY: Published data are conflicting with some studies reporting an increase in adverse perinatal outcomes in association with prior recurrent miscarriage while others report little or no increase. Large-scale population-based studies have been lacking. STUDY DESIGN, SIZE, DURATION: We performed a retrospective cohort study of 30 053 women with a singleton pregnancy who booked for antenatal care and delivery between January 2008 and July 2011. PARTICIPANTS/MATERIALS, SETTING,
METHODS: All women who attended a university affiliated hospital in Ireland had a detailed obstetric history taken, recording the outcome of all previous pregnancies. We compared the obstetric and perinatal outcomes of 2030 women (6.8%) who had a history of three or more miscarriages (recurrent miscarriage) with the outcomes of 28 023 women (93.2%) who did not. Logistic regression analyses were performed, adjusting for potential confounding factors. MAIN RESULTS AND THE ROLE OF CHANCE: Women with a history of recurrent miscarriage were more likely to be obese, to have undergone assisted conception, to have had a previous perinatal death, and to be delivered by scheduled Caesarean section. Recurrent miscarriage was associated with an increased incidence of preterm birth (<37 weeks gestation, 8.1 versus 5.5%, adjOR 1.54; 95% CI 1.29-1.84), very preterm birth (<32 weeks gestation, 2.2 versus 1.2%, adjOR 1.80; 95% CI 1.28-2.53), and perinatal death (1.2 versus 0.5%, adjOR 2.66; 95% CI 1.70-4.14). The results were similar for both primary and secondary recurrent miscarriage. LIMITATIONS, REASONS FOR CAUTION: This is a retrospective cohort study and while regression analyses adjusted for potential confounding factors, residual confounding may persist. The strict definition of recurrent miscarriage is three consecutive miscarriages and while each woman in the study group had three or more miscarriages, they were only confirmed to be consecutive in the primary RM group. The affected women have not been categorized according to aetiology of recurrent miscarriage and it may be that adverse outcomes differ according to aetiological subgroup. WIDER IMPLICATIONS OF THE
FINDINGS: This study highlights the need for specialist obstetric care for women who have had three or more previous miscarriages, particularly in relation to the risk of preterm delivery. STUDY FUNDING/COMPETING INTERESTS: There was no specific funding obtained for this study and there are no conflict of interests.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cohort study; perinatal outcomes; predictors; recurrent miscarriage

Mesh:

Year:  2015        PMID: 25759495     DOI: 10.1093/humrep/dev044

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Plasma level of mannose-binding lectin is associated with the risk of recurrent pregnancy loss but not pregnancy outcome after the diagnosis.

Authors:  C Nørgaard-Pedersen; L H Rom; R Steffensen; U S Kesmodel; O B Christiansen
Journal:  Hum Reprod Open       Date:  2022-06-07

Review 2.  Defining recurrent implantation failure: a profusion of confusion or simply an illusion?

Authors:  Audrey S Garneau; Steven L Young
Journal:  Fertil Steril       Date:  2021-12       Impact factor: 7.490

3.  Adverse Pregnancy Outcomes of Patients with History of First-Trimester Recurrent Spontaneous Abortion.

Authors:  Jing Yang; Yan Wang; Xiao-Ye Wang; Yan-Yu Zhao; Jing Wang; Yang-Yu Zhao
Journal:  Biomed Res Int       Date:  2017-07-17       Impact factor: 3.411

4.  Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study.

Authors:  Maria C Magnus; Allen J Wilcox; Nils-Halvdan Morken; Clarice R Weinberg; Siri E Håberg
Journal:  BMJ       Date:  2019-03-20

5.  Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children's Study.

Authors:  Mayumi Sugiura-Ogasawara; Takeshi Ebara; Yasuyuki Yamada; Naoto Shoji; Taro Matsuki; Hirohisa Kano; Takahiro Kurihara; Toyonori Omori; Motohiro Tomizawa; Maiko Miyata; Michihiro Kamijima; Shinji Saitoh
Journal:  Am J Reprod Immunol       Date:  2018-12-13       Impact factor: 3.886

6.  Gestational and perinatal outcomes in recurrent miscarriages couples treated with lymphocyte immunotherapy.

Authors:  Manoel Sarno; Marcelo Borges Cavalcante; Marla Niag; Kleber Pimentel; Ivana Luz; Bianca Figueiredo; Tatiana Michelon; Jorge Neumann; Simone Lima; Isabela Nelly Machado; Edward Araujo Júnior; Ricardo Barini
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-07

7.  Pregnancy complications recur independently of maternal vascular malperfusion lesions.

Authors:  Julian K Christians; Maria F Huicochea Munoz
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

8.  Impact of Recurrent Miscarriage on Maternal Outcomes in Subsequent Pregnancy: The Mutaba'ah Study.

Authors:  Nasloon Ali; Iffat Elbarazi; Saad Ghazal-Aswad; Fatima Al-Maskari; Rami H Al-Rifai; Abderrahim Oulhaj; Tom Loney; Luai A Ahmed
Journal:  Int J Womens Health       Date:  2020-12-08

9.  Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history.

Authors:  Christiane Kling; Julia Magez; Jürgen Hedderich; Sören von Otte; Dieter Kabelitz
Journal:  Arch Gynecol Obstet       Date:  2016-01-21       Impact factor: 2.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.